Hello, Fool! | Login | Signup | My Fool
Oct 6, 2008 10:31 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
AlphaMale11 (< 20) Submitted: 4/09/08 3:17 AM : Start Price: $62.49 CELG Score: 12.89
growth medical stock
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK